- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
American Oncology Network Remains Committed to Closing the Gap in Cancer Care
The American Oncology Network is committed to reducing health inequities and close the gap in cancer care.
Cancer remains the leading cause of death in the United States, with more than 1.8 million Americans receiving a cancer diagnosis every year and 600,000 dying. While there have been advances in prevention, diagnosis, and treatment, barriers to care continue to negatively impact cancer care.
Most Americans receiving cancer treatment do so in community oncology practices, which are able to cloes the gap in cancer care becaues they provide easy and convenient access to care and a cmoprehensive range of treatments close to the patient's home. With 70 clinics in 16 states, the American Oncology Network (AON), continues to strive to close the cancer care gap by providing affordable care that is close to home.
“We have made great strides in just three years,” AON CEO Todd Schonherz said in a statement. “Close to 160,000 patients have received treatment at AON clinics across the country and we’ve welcomed over 70,000 new patients. Our in-house laboratory has processed over 7.7 million clinical lab tests and almost 6100 pathology specimens. And our specialty pharmacy has delivered over 63,540 scripts.”
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
What We’re Reading: New HPV Screenings; Lung Cancer Pills; Migraine Relief Device
November 9th 2023A study suggests that human papillomavirus (HPV) screenings should be updated due to effective HPV vaccines; a new study shows that osimertinib (Tagrisso, AstraZeneca) reduced both the 5-year risk of recurrent cancer and the risk of death in patients with stage 1B to 3A lung cancer; a new smartphone-controlled technology could help those who suffer from migraines.
Read More
